42 related articles for article (PubMed ID: 6386387)
1. Morphologic changes in rat urothelial cells during carcinogenesis: II. Image cytometry.
Young IT; Vanderlaan M; Kromhout L; Jensen R; Grover A; King E
Cytometry; 1984 Sep; 5(5):454-62. PubMed ID: 6386387
[TBL] [Abstract][Full Text] [Related]
2. Morphologic changes in rat urothelial cells during carcinogenesis: I. Histologic and cytologic changes.
King EB; Vanderlaan M; Jensen RH; Kromhout LK; Hoffman JW
Cytometry; 1984 Sep; 5(5):447-53. PubMed ID: 6489059
[TBL] [Abstract][Full Text] [Related]
3. E-cadherin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in rats.
Oliveira PA; Colaço A; De la Cruz LF; Lopes P; Lopes C
J Exp Clin Cancer Res; 2006 Sep; 25(3):425-32. PubMed ID: 17167984
[TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
Lee CC; Yamamoto S; Wanibuchi H; Wada S; Sugimura K; Kishimoto T; Fukushima S
Cancer Res; 1997 Nov; 57(21):4765-76. PubMed ID: 9354438
[TBL] [Abstract][Full Text] [Related]
5. The use of correspondence analysis in the assessment of morphologic changes during carcinogenesis.
Gelsema ES; Hunink M; Queiros CE; Timmers T
Cytometry; 1984 Sep; 5(5):463-8. PubMed ID: 6386388
[TBL] [Abstract][Full Text] [Related]
6. Lack of enhancing effect of mucosal regeneration following ulceration of the urinary bladder on N-butyl-N-(4-hydroxybutyl)nitrosamine carcinogenesis in rats.
Shirai T
Cancer Res; 1980 Oct; 40(10):3709-12. PubMed ID: 7438054
[TBL] [Abstract][Full Text] [Related]
7. DNA cytometry and kinetics of rat urothelial lesions during chemical carcinogenesis.
Palmeira C; Oliveira PA; Arantes-Rodrigues R; Colaço A; De la Cruz PL; Lopes C; Santos L
Oncol Rep; 2009 Jan; 21(1):247-52. PubMed ID: 19082469
[TBL] [Abstract][Full Text] [Related]
8. [Histological study of urinary bladder tumor: DNA of rat urinary bladder tumor caused by N-butyl-N-(4-hydroxybutyl) nitrosamine and that of human bladder tumor].
Murase T; Kobayashi O; Aota Y; Mitsuta H; Koshikawa T
Hinyokika Kiyo; 1983 Mar; 29(3):303-10. PubMed ID: 6677123
[TBL] [Abstract][Full Text] [Related]
9. An objective morphologic parameter to aid in the diagnosis of flat urothelial carcinoma in situ.
Milord RA; Lecksell K; Epstein JI
Hum Pathol; 2001 Sep; 32(9):997-1002. PubMed ID: 11567231
[TBL] [Abstract][Full Text] [Related]
10. DNA content analysis, expression of Ki-67 and p53 in rat urothelial lesions induced by N-butyl-N-(4-hydroxybutyl) nitrosamine and treated with mitomycin C and bacillus Calmette-Guérin.
Oliveira PA; Palmeira C; Colaço A; de la Cruz LF; Lopes C
Anticancer Res; 2006; 26(4B):2995-3004. PubMed ID: 16886626
[TBL] [Abstract][Full Text] [Related]
11. Possible mechanistic roles of anatomical and functional vascular changes in rat urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Tatematsu M; Lurie AG; Rippey RM; Conran PB; Arai M; Fukushima S; Ito N
Cancer Res; 1984 Jan; 44(1):278-84. PubMed ID: 6690039
[TBL] [Abstract][Full Text] [Related]
12. Quantitative assessment of bladder cancer by nuclear texture analysis using automated high resolution image cytometry.
Gschwendtner A; Hoffmann-Weltin Y; Mikuz G; Mairinger T
Mod Pathol; 1999 Aug; 12(8):806-13. PubMed ID: 10463483
[TBL] [Abstract][Full Text] [Related]
13. Drugs, food additives and natural products as promoters in rat urinary bladder carcinogenesis.
Ito N; Fukushima S; Shirai T; Hagiwara A; Imaida K
IARC Sci Publ; 1984; (56):399-407. PubMed ID: 6536604
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of urinary bladder tumorigenesis by carcinogen-exposed stroma.
Uchida K; Samma S; Momose H; Kashihara N; Rademaker A; Oyasu R
J Urol; 1990 Mar; 143(3):618-21. PubMed ID: 2304182
[TBL] [Abstract][Full Text] [Related]
15. High susceptibility of p53(+/-) knockout mice in N-butyl-N-(4-hydroxybutyl)nitrosamine urinary bladder carcinogenesis and lack of frequent mutation in residual allele.
Ozaki K; Sukata T; Yamamoto S; Uwagawa S; Seki T; Kawasaki H; Yoshitake A; Wanibuchi H; Koide A; Mori Y; Fukushima S
Cancer Res; 1998 Sep; 58(17):3806-11. PubMed ID: 9731488
[TBL] [Abstract][Full Text] [Related]
16. Chemopreventive effects of nimesulide, a selective cyclooxygenase-2 inhibitor, on the development of rat urinary bladder carcinomas initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Okajima E; Denda A; Ozono S; Takahama M; Akai H; Sasaki Y; Kitayama W; Wakabayashi K; Konishi Y
Cancer Res; 1998 Jul; 58(14):3028-31. PubMed ID: 9679967
[TBL] [Abstract][Full Text] [Related]
17. Dose response of saccharin in induction of urinary bladder hyperplasias in Fischer 344 rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Nakanishi K; Hagiwara A; Shibata M; Imaida K; Tatematsu M; Ito N
J Natl Cancer Inst; 1980 Nov; 65(5):1005-10. PubMed ID: 6933236
[TBL] [Abstract][Full Text] [Related]
18. Enhancement by urine of urinary bladder carcinogenesis.
Oyasu R; Hirao Y; Izumi K
Cancer Res; 1981 Feb; 41(2):478-81. PubMed ID: 7448795
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal characteristics and malignancy of urothelial cells from carcinogen-treated rats.
Debiec-Rychter M; Zukowski K; Wang CY
J Natl Cancer Inst; 1989 Mar; 81(5):361-7. PubMed ID: 2915372
[TBL] [Abstract][Full Text] [Related]
20. Quantitative evaluation of the progressive nuclear abnormalities in urothelial papillary lesions.
Montironi R; Scarpelli M; Ansuini G; Pisani E; Del Fiasco S; Mariuzzi GM
Appl Pathol; 1986; 4(1-2):65-73. PubMed ID: 3580195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
